The Monthly Dealtracker January 2026 review captures India’s deal environment with data on M&A, private equity, capital market values, sector highlights and macro trends shaping investment momentum and strategic transactions at the start of 2026.
The evolving macroeconomic landscape and dynamic business environment continually present challenges to large and expanding businesses, especially those with international operations.
Grant Thornton offers a solution with our Dealtracker publication, providing comprehensive deal insights at your fingertips. This publication delivers highlights, sector updates, and in-depth analyses of current opportunities and challenges in the industry.
With nearly two decades of active tracking in PE investment and M&A deal activities, our flagship publication, Dealtracker, remains a reliable source. We emphasise that both these activities will play a pivotal role as the Indian economy aims to regain its high growth trajectory. To achieve this, India Inc. must intensify its focus on both private equity investments, and mergers and acquisitions.
The report features extensive data on VC/PE investments and M&A deal activities, offering insights into industry growth across sectors and companies of various sizes. Our coverage is comprehensive, capturing deals within the Indian territory and providing timely reports that offer an overview of deal sentiment in India.
Our suite of coverage includes:
- Mergers and acquisitions deals
- Private equity/venture capital investments
- IPOs
- QIPs
Read more
Thought leadership
Monthly Dealtracker: January 2026
Thought leadership
Annual Dealtracker: 2026
Annual Dealtracker 2025 analyses India’s record deal activity, including M&A, PE/VC, and sector trends. The report highlights macro resilience, policy support, and deal momentum into 2026.
Thought leadership
Monthly Dealtracker: November2025
November 2025 marked a significant milestone for India’s deal environment, reflecting strong momentum across mergers and acquisitions and private equity transactions.
Thought leadership
Monthly Dealtracker: October 2025
India’s deal activity in October 2025 reflected strong momentum across mergers, acquisitions, private equity, and public listings.
Thought leadership
Pharma and Healthcare Dealtracker: Q3 2025
The Pharma and Healthcare Dealtracker Q3 2025 by Grant Thornton Bharat analyses India’s evolving life sciences ecosystem, highlighting a 28% surge in deal volumes and a 166% rise in values. The report explores M&A, private equity, and capital market activity shaping pharma, healthcare, and biotech growth.
Thought leadership
Technology Dealtracker: Q3 2025
The Q3 2025 edition of the Technology Dealtracker outlines this directional change, highlighting strategic movements across private equity and M&A, especially in mid-market and outbound segments.
News & updates
Grant Thornton Bharat Dealtracker: India Inc. sees USD 8.7 billion in deals for August amid geopolitical challenges, telecom and EV sectors shine
09 Sep 2024According to the Grant Thornton Bharat Dealtracker, excluding IPOs and QIPs, August 2024 deal activity witnessed a significant surge, with a total of 179 deals, amounting to USD 8.7 billion, marking a 63% increase in value compared to July.
Indian dealmaking soars to new heights in Q2 2024 in last 2 years: PE activity drives surge amid strong domestic investment and sectoral growth
05 Jul 2024According to the Grant Thornton Bharat Dealtracker, Q2 2024, Indian dealmaking witnessed an overall 501 deals, valued at USD 21.4 billion.
Grant Thornton Bharat acts as exclusive advisor to Biorad Medisys for its fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II
16 May 2024Grant Thornton Bharat acts as exclusive advisor to Biorad Medisys for its fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II